Saroja Pharma Industries India share price
You have to be logged in to add this to Watchlist.- ₹36.05(0.00%)February 4, 2026 15:40:00 PM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 3.76 K
Saroja Pharma Industries India is trading 0.00% upper at Rs 36.05 as compared to its last closing price. Saroja Pharma Industries India has been trading in the price range of 0.00 & 0.00. Saroja Pharma Industries India has given -9.88% in this year & 0.00% in the last 5 days. Saroja Pharma Industries India has TTM P/E ratio 14.21 as compared to the sector P/E of 30.79.The company posted a net profit of 0.57 Crores in its last quarter.Listed peers of Saroja Pharma Industries India include Divi's Laboratories (-0.13%), Sun Pharmaceutical Industries (-0.97%), Torrent Pharmaceuticals (-0.18%).The Mutual Fund holding in Saroja Pharma Industries India was at -% in . The MF holding has - from the last quarter. The FII holding in Saroja Pharma Industries India was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 13, 2026, 11:00 PM UTC
- Debt To EquityHigher than industry0.60The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-3.56The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,180.45 | -0.13 | 1,64,071.53 | 73.22 | 10.73 | 0.50 | 0.01 |
| Sun Pharmaceutical Industries | Neutral | 1,698.00 | -0.97 | 4,07,849.42 | 33.29 | 5.3 | 1.00 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,074.05 | -0.18 | 1,37,562.02 | 69.54 | 17.66 | 0.81 | 17.62 |
| Cipla | Bearish | 1,331.70 | 0.16 | 1,07,570.97 | 20.31 | 3.43 | 0.98 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,268.00 | -0.51 | 1,05,788.83 | 17.93 | 3.02 | 0.66 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-05-29 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE0PCL01011
- BSE Code
- NSE CodeSAROJA
Saroja Pharma Industries India is trading at 36.05 as on Wed Feb 04 2026 10:10:00. This is 0.00% upper as compared to its previous closing price of 36.05.
The market capitalization of Saroja Pharma Industries India is 14.49 Cr as on Wed Feb 04 2026 10:10:00.
The 52 wk high for Saroja Pharma Industries India is 60.00 whereas the 52 wk low is 32.50
Saroja Pharma Industries India can be analyzed on the following key metrics -
- TTM P/E: 14.21
- Sector P/E: 30.79
- Dividend Yield: 0.00%
- D/E ratio: 0.65
Saroja Pharma Industries India reported a net profit of 1.03 Cr in 2025.